SCHEMBL26634661

SCHEMBL26634661

CC1CC(=O)N(CCNC(=O)CSCC(=O)O)C1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ FABP3 P05413 1/20 0.36
▸ FABP4 P15090 1/20 0.36
▸ GAA P10253 1/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ CYP2C19 P33261 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21383860 1.00 USP2 (0.37) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL21389303 1.00 USP2 (0.37) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL26746513 0.90 KMT2A (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26746803 0.88 ALDH1A1 (0.44) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL26746797 0.88 ALDH1A1 (0.44) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL24796175 0.88 ALDH1A1 (0.44) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL21384008 0.86 APEX1 (0.42) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL24796275 0.86 APEX1 (0.42) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL24796375 0.86 APEX1 (0.42) USP2ALDH1A1FABP3FABP4GAA
SCHEMBL24796314 0.84 L3MBTL1 (0.43) ALDH1A1GAACYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed
CN-112236161-A Modulators of G protein-coupled receptors 卡莫特治疗学股份有限公司 2021-01-15 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR USP2 2595/4885ALDH1A1 3305/4885FABP3 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback